BIOMAT Database Logo BIOMAT Database Logo

Ovarian hyperstimulation after administration of triptorelin therapy to a patient with polycystic ovary syndrome. 2000

S Campo, and I Bezzi, and N Garcea
Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.

UI MeSH Term Description Entries
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016471 Ovarian Hyperstimulation Syndrome A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES. Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous,Hyperstimulation Syndrome, Ovarian,Hyperstimulation Syndromes, Ovarian,Ovarian Hyperstimulation Syndromes
D017329 Triptorelin Pamoate A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE with D-tryptophan substitution at residue 6. D-Trp-6-LH-RH,LHRH, Trp(6)-,Triptorelin,6-D-Tryptophan-Luteinizing Hormone-Releasing Factor (Pig),AY-25650,CL-118532,Decapeptyl,Decapeptyl Depot,Decapeptyl LP,Decapeptyl Trimestral,GnRH, Trp(6)-,LHRH, Tryptophyl(6)-,Trelstar,Triptorelin Embonate,Wy-42462,AY 25650,AY25650,CL 118532,CL118532,Embonate, Triptorelin,Pamoate, Triptorelin,Trimestral, Decapeptyl,Wy 42462,Wy42462

Related Publications

S Campo, and I Bezzi, and N Garcea
Ovarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis.
October 2002, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
S Campo, and I Bezzi, and N Garcea
Ovarian hyperstimulation in polycystic ovary syndrome during therapy with leuprolide acetate.
November 1989, Fertility and sterility,
S Campo, and I Bezzi, and N Garcea
Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome.
December 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
S Campo, and I Bezzi, and N Garcea
Analysis of 24 cases of polycystic ovary syndrome after failed controlled ovarian hyperstimulation.
July 2019, Clinical medicine (London, England),
S Campo, and I Bezzi, and N Garcea
Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome.
December 2002, Fertility and sterility,
S Campo, and I Bezzi, and N Garcea
[A relation between the polycystic ovary syndrome and the status of ovarian hyperstimulation syndrome in IVF patients after controlled hyperstimulation].
April 2011, Ceska gynekologie,
S Campo, and I Bezzi, and N Garcea
Persistent megalocystic ovaries after ovarian hyperstimulation syndrome in a postpartum patient with polycystic ovarian syndrome: a case report.
September 2018, Journal of ovarian research,
S Campo, and I Bezzi, and N Garcea
Ovarian hyperstimulation syndrome caused by GnRH-analogue treatment without gonadotropin therapy in a patient with polycystic ovarian syndrome.
October 1998, Acta obstetricia et gynecologica Scandinavica,
S Campo, and I Bezzi, and N Garcea
Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease.
July 1992, American journal of obstetrics and gynecology,
S Campo, and I Bezzi, and N Garcea
Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome.
October 2004, Best practice & research. Clinical obstetrics & gynaecology,
Copied contents to your clipboard!